| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-97637SS | |||
| BSA Free | NBP1-97637-100ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76843-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-56310SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-77234-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-90011-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-27127-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76774-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-27126-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76767-0.025mg | |||
![Immunohistochemistry-Paraffin: BAFF/BLyS/TNFSF13B Antibody (Buffy-2) [NBP1-97622] - Human skin with marked lymphocyte infiltration. Lymphocytes and lymphatic vessels were membranous or cytoplasmic positive for BAFF. Nuclei of keratinocytes were also stained. Buffy2 (working dilution 2ug/mL). detected with Leica BOND Refine polymer (DAB) kit. Rabbit ant-rat IgG+M as a linker antibody pretreatment: basic solution (BOND ER2). IHC-P image submitted by a verified customer review.](http://images.novusbio.com/fullsize/BAFF-BLyS-TNFSF13B-Antibody-Buffy-2-Immunohistochemistry-Paraffin-NBP1-97622-img0002.jpg "Immunohistochemistry-Paraffin: BAFF/BLyS/TNFSF13B Antibody (Buffy-2) [NBP1-97622] - Human skin with marked lymphocyte infiltration. Lymphocytes and lymphatic vessels were membranous or cytoplasmic positive for BAFF. Nuclei of keratinocytes were also stained. Buffy2 (working dilution 2ug/mL). detected with Leica BOND Refine polymer (DAB) kit. Rabbit ant-rat IgG+M as a linker antibody pretreatment: basic solution (BOND ER2). IHC-P image submitted by a verified customer review.")
![Immunohistochemistry-Paraffin: TNFSF13B Antibody (Buffy-2) [NBP1-97622] - Staining of paraffin section of synovial tissue from a patient with Rheumatoid Arthritis. Arrows indicate vessels (20x) staining positive for BAFF using Buffy-2. Method: Tissues are in paraffin sections. Sections are de-waxed and rehydrated, then cooked. Sections are stained in wet boxes, rehydrated and finally prepared as coverslip slides using Eukitt solution.](http://images.novusbio.com/fullsize/TNFSF13B-Antibody-Buffy-2-Immunohistochemistry-Paraffin-NBP1-97622-img0001.jpg)
![Immunohistochemistry: BCMA/TNFRSF17 Antibody (Vicky-1) [NBP1-97637] - Immunostaining of HEK 293 cells transfected with a human BCMA expression plasmid (left panel), or mock transfected (right panel). Method: 3 days after transfection of cells with the indicated constructs, cells were fixed with acetone or 4% formaldehyde for 5 min. at room temperature. Slides were blocked with normal IgG, and incubated for 1 hour with 5ug/ml MAb to BCMA (human) (Vicky-1) in 1% BSA in 1x PBS. After washes in PBS, samples were incubated with the secondary antibody for 1 hour, washed in PBS and revealed with StreptABComplex/HRP (Vector) and AEC.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Vicky-1-Immunohistochemistry-NBP1-97637-img0007.jpg "Immunohistochemistry: BCMA/TNFRSF17 Antibody (Vicky-1) [NBP1-97637] - Immunostaining of HEK 293 cells transfected with a human BCMA expression plasmid (left panel), or mock transfected (right panel). Method: 3 days after transfection of cells with the indicated constructs, cells were fixed with acetone or 4% formaldehyde for 5 min. at room temperature. Slides were blocked with normal IgG, and incubated for 1 hour with 5ug/ml MAb to BCMA (human) (Vicky-1) in 1% BSA in 1x PBS. After washes in PBS, samples were incubated with the secondary antibody for 1 hour, washed in PBS and revealed with StreptABComplex/HRP (Vector) and AEC.")
![Flow Cytometry: BCMA/TNFRSF17 Antibody (Vicky-1) [NBP1-97637] - Analysis using the PE conjugate of NBP1-97637. Staining of 10^6 U266 cells using BCMA (human), mAb (Vicky-1) (PE conjugate) at a concentration of 10ug/ml.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Vicky-1-Flow-Cytometry-NBP1-97637-img0011.jpg)
![Flow Cytometry: BCMA/TNFRSF17 Antibody (Vicky-1) [NBP1-97637] - Detection of endogenous human BCMA with MAb to BCMA (human) (Vicky-1). Method: U266 cells (2x10^5) were incubated on ice for 30 min. with 0.2ug of MAb to BCMA (human) (Vicky-1) or an isotype control in 25ul FACS buffer (PBS, 5% fetal calf serum, 0.02% azide). The primary antibody was revealed with PAb to Rat IgG (R-PE) and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Vicky-1-Flow-Cytometry-NBP1-97637-img0006.jpg)
![Flow Cytometry: BCMA/TNFRSF17 Antibody (Vicky-1) [NBP1-97637] - Analysis using the FITC conjugate of NBP1-97637. Staining of 10^6 Jurkat cells using BCMA (human), mAb (Vicky-1) (FITC conjugate) at a concentration of 50ug/ml.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Vicky-1-Flow-Cytometry-NBP1-97637-img0010.jpg)
![Western Blot: BAFF/BLyS/TNFSF13B Antibody [NBP1-76843] - Western Blot Validation with Recombinant Protein. Loading: 30 ng of human BAFF recombinant protein per lane. Antibodies: BAFF/BLyS/TNFSF13B NBP1-76843 (Lane 1: 0.25 ug/mL; Lane 2: 0.5 ug/mL and Lane 3: 1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Observed at around 18kDa.](http://images.novusbio.com/fullsize/BAFF-BLyS-TNFSF13B-Antibody-Western-Blot-NBP1-76843-img0005.jpg "<b>Expression of Tagged Proteins Validation. </b>Western Blot: BAFF/BLyS/TNFSF13B Antibody [NBP1-76843] - Western Blot Validation with Recombinant Protein. Loading: 30 ng of human BAFF recombinant protein per lane. Antibodies: BAFF/BLyS/TNFSF13B NBP1-76843 (Lane 1: 0.25 ug/mL; Lane 2: 0.5 ug/mL and Lane 3: 1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. Observed at around 18kDa.")
![<b>Expression of Tagged Proteins Validation. </b>Western Blot: BAFF/BLyS/TNFSF13B Antibody [NBP1-76843] - Western Blot Validation in Human, Mouse and Rat Cell Lines. Loading: 15 ug of lysates per lane. Antibodies: BAFF/BLyS/TNFSF13B NBP1-76843 (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/BAFF-BLyS-TNFSF13B-Antibody-Western-Blot-NBP1-76843-img0004.jpg)
![Immunocytochemistry/ Immunofluorescence: BAFF/BLyS/TNFSF13B Antibody - BSA Free [NBP1-76843] - Validation of BAFF/BLyS/TNFSF13B in HL60 Cells. Immunocytochemical analysis of HL60 cells using anti-BAFF/BLyS/TNFSF13B antibody at 1 ug/ml. Cells was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.](http://images.novusbio.com/fullsize/nbp1-76843_rabbit-polyclonal-baff-blys-tnfsf13b-antibody-271120242010580.jpg)
![Western Blot: BAFF/BLyS/TNFSF13B Antibody - BSA Free [NBP1-76843] - Validation in Human HL60 Cell Lysate (H) and Mouse Spleen Lysate (M). Loading: 15 ug of lysates per lane.Antibodies: BAFF/BLyS/TNFSF13B (1 u/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/nbp1-76843_rabbit-polyclonal-baff-blys-tnfsf13b-antibody-2711202420285892.jpg)
![Immunocytochemistry/ Immunofluorescence: BAFF/BLyS/TNFSF13B Antibody - BSA Free [NBP1-76843] - Validation of BAFF/BLyS/TNFSF13B in Human Spleen Tissue. Immunofluorescent analysis of 4% paraformaldehyde-fixed human spleen tissue labeling BAFF/BLyS/TNFSF13B with at 20 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue).](http://images.novusbio.com/fullsize/nbp1-76843_rabbit-polyclonal-baff-blys-tnfsf13b-antibody-2711202420285848.gif)
![Western Blot: APRIL/TNFSF13 Antibody (Aprily-8) [NBP1-97587] - Total cell extracts from HEK 293 cells transfected with the indicated expression vector. Aprily-8 reacts specifically with human APRIL.Method: 10ug of protein was applied to the gel. Revealed with Aprily-8 (1ug/ml) and HRP-coupled anti-mouse secondary antibody (1:4000).Note: The human APRIL construct used in this experiment is an uncleavable fusion protein between human BAFF (aa 1-132) and human APRIL (aa 93-233).](http://images.novusbio.com/fullsize/APRIL-TNFSF13-Antibody-Aprily-8-Western-Blot-NBP1-97587-img0006.jpg "Western Blot: APRIL/TNFSF13 Antibody (Aprily-8) [NBP1-97587] - Total cell extracts from HEK 293 cells transfected with the indicated expression vector. Aprily-8 reacts specifically with human APRIL.Method: 10ug of protein was applied to the gel. Revealed with Aprily-8 (1ug/ml) and HRP-coupled anti-mouse secondary antibody (1:4000).Note: The human APRIL construct used in this experiment is an uncleavable fusion protein between human BAFF (aa 1-132) and human APRIL (aa 93-233).")
![Immunohistochemistry-Paraffin: APRIL/TNFSF13 Antibody (Aprily-8) [NBP1-97587] - Immunostaining of HEK 293 cells transfected with a human APRIL expression plasmid (left panels), or mock transfected (right panel) by Aprily-8.](http://images.novusbio.com/fullsize/APRIL-TNFSF13-Antibody-Aprily-8-Immunohistochemistry-Paraffin-NBP1-97587-img0005.jpg)
![Flow Cytometry: APRIL/TNFSF13 Antibody (Aprily-8) [NBP1-97587] - Analysis of cells with MAb to APRIL (Aprily-8).Method: HEK 293 cells were mock transfected or transfected with an expression plasmid coding for a non-cleavable human APRIL. Cells (5x10^5) were incubated on ice for 30 min. in 50ul FACS buffer (PBS, 5% fetal calf serum, 0.02% azide) containing 10ug/ml of Aprily-8 antibody. After washing in FACS buffer, FITC-conjugated antibody to mouse IgG was added. Cells were incubated on ice for 30 min., washed and analyzed by flow cytometry.](http://images.novusbio.com/fullsize/APRIL-TNFSF13-Antibody-Aprily-8-Flow-Cytometry-NBP1-97587-img0004.jpg)
![Western Blot: BAFF/BLyS/TNFSF13B Antibody [NB100-56310] - Analysis of BAFF/BLyS/TNFSF13B in mouse and human lysates using BLyS antibody at 2 ug/ml. Lane A: mouse testis, Lane B: mouse thymus, Lane C: mouse spleen, and Lane D: HL-60 cells (human). Goat anti-rabbit Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/BAFF-BLyS-TNFSF13B-Antibody-Western-Blot-NB100-56310-img0003.jpg "Western Blot: BAFF/BLyS/TNFSF13B Antibody [NB100-56310] - Analysis of BAFF/BLyS/TNFSF13B in mouse and human lysates using BLyS antibody at 2 ug/ml. Lane A: mouse testis, Lane B: mouse thymus, Lane C: mouse spleen, and Lane D: HL-60 cells (human). Goat anti-rabbit Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.")
![Western Blot: BAFFR/TNFRSF13C Antibody [NBP1-77234] - Human (H), mouse (M), and rat (R) spleen tissue lysates with BAFF Receptor antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/BAFFR-TNFRSF13C-Antibody-Western-Blot-NBP1-77234-img0002.jpg "Western Blot: BAFFR/TNFRSF13C Antibody [NBP1-77234] - Human (H), mouse (M), and rat (R) spleen tissue lysates with BAFF Receptor antibody at 5 ug/ml.")
![Immunohistochemistry: BAFFR/TNFRSF13C Antibody - BSA Free [NBP1-77234] - Immunohistochemistry of BAFF Receptor in human tonsil tissue with BAFF Receptor antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/nbp1-77234_rabbit-polyclonal-baffr-tnfrsf13c-antibody-2711202420212393.jpg)
![Immunohistochemistry: BAFFR/TNFRSF13C Antibody - BSA Free [NBP1-77234] - Immunohistochemistry of BAFFR/TNFRSF13C in human spleen tissue with BAFFR/TNFRSF13C antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/nbp1-77234_rabbit-polyclonal-baffr-tnfrsf13c-antibody-2711202419241377.gif)
![Immunocytochemistry/ Immunofluorescence: BAFFR/TNFRSF13C Antibody - BSA Free [NBP1-77234] - Immunofluorescence of BAFFR/TNFRSF13C in human spleen tissue with BAFFR/TNFRSF13C antibody at 20 ug/ml.Red: BAFF Receptor Antibody Blue: DAPI staining](http://images.novusbio.com/fullsize/nbp1-77234_rabbit-polyclonal-baffr-tnfrsf13c-antibody-2711202420141949.gif)
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: BAFF R/TNFRSF13C Antibody [NBP1-90011] - Staining of human tonsil shows high expression.](http://images.novusbio.com/fullsize/BAFF-R-TNFRSF13C-Antibody-Immunohistochemistry-Paraffin-NBP1-90011-img0006.jpg)
![Immunohistochemistry-Paraffin: BAFF R/TNFRSF13C Antibody [NBP1-90011] - Staining of human cerebral cortex shows low expression as expected.](http://images.novusbio.com/fullsize/BAFF-R-TNFRSF13C-Antibody-Immunohistochemistry-Paraffin-NBP1-90011-img0005.jpg)
![Western Blot: BAFFR/TNFRSF13C Antibody (5A9B6) [NBP3-27127] - Analysis using BAFFR/TNFRSF13C mouse mAb against C6 (1) cell lysate.](http://images.novusbio.com/fullsize/nbp3-27127_mouse-baffr-tnfrsf13c-mab-5a9b6-bsa-free-104202491581.jpg%3Fv=1666702827 "Western Blot: BAFFR/TNFRSF13C Antibody (5A9B6) [NBP3-27127] - Analysis using BAFFR/TNFRSF13C mouse mAb against C6 (1) cell lysate.")
![Flow Cytometry: BAFFR/TNFRSF13C Antibody (5A9B6) [NBP3-27127] - Analysis of Raji cells using BAFFR/TNFRSF13C mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/nbp3-27127_mouse-baffr-tnfrsf13c-mab-5a9b6-bsa-free-1042024920245.jpg%3Fv=1666702828)
![Western Blot: BAFFR/TNFRSF13C Antibody (5A9B6) [NBP3-27127] - Analysis using BAFFR/TNFRSF13C mAb against human BAFFR/TNFRSF13C (AA: extra 1-78) recombinant protein. (Expected MW is 34 kDa)](http://images.novusbio.com/fullsize/nbp3-27127_mouse-baffr-tnfrsf13c-mab-5a9b6-bsa-free-104202491580.jpg%3Fv=1666702827)
![Western Blot: BAFFR/TNFRSF13C Antibody (5A9B6) [NBP3-27127] - Analysis using BAFFR/TNFRSF13C mAb against HEK293 (1) and BAFFR/TNFRSF13C (AA: extra 1-78)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/nbp3-27127_mouse-baffr-tnfrsf13c-mab-5a9b6-bsa-free-1042024915847.jpg%3Fv=1666702827)
![ELISA: BAFFR/TNFRSF13C Antibody (5A9B6) [NBP3-27127] - Black line: Control Antigen (100 ng); Purple line: Antigen (10 ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng)](http://images.novusbio.com/fullsize/nbp3-27127_mouse-baffr-tnfrsf13c-mab-5a9b6-bsa-free-1042024916243.jpg%3Fv=1666702827)
![Western Blot: BCMA/TNFRSF17 Antibody [NBP1-76774] - Human spleen (A) tissue lysate, K562 (B), and U937 (C) cell lysates with BCMA antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Western-Blot-NBP1-76774-img0002.jpg "Western Blot: BCMA/TNFRSF17 Antibody [NBP1-76774] - Human spleen (A) tissue lysate, K562 (B), and U937 (C) cell lysates with BCMA antibody at 5 ug/ml.")
![Immunohistochemistry-Paraffin: BCMA/TNFRSF17 Antibody [NBP1-76774] - Human spleen tissue with BCMA antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Immunohistochemistry-Paraffin-NBP1-76774-img0005.jpg)
![Immunocytochemistry/ Immunofluorescence: BCMA/TNFRSF17 Antibody - BSA Free [NBP1-76774] - Immunofluorescence of BCMA/TNFRSF17 in Human Spleen tissue with BCMA/TNFRSF17 antibody at 10 u/mL.](http://images.novusbio.com/fullsize/nbp1-76774_rabbit-polyclonal-bcma-tnfrsf17-antibody-2711202420285861.jpg)
![Immunohistochemistry: BCMA/TNFRSF17 Antibody - BSA Free [NBP1-76774] - Immunohistochemistry of BCMA/TNFRSF17 in human spleen tissue with BCMA/TNFRSF17 antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76774_rabbit-polyclonal-bcma-tnfrsf17-antibody-2711202420414573.gif)
![Western Blot: BAFFR/TNFRSF13C Antibody (5A9B10) [NBP3-27126] - Analysis using BAFFR/TNFRSF13C mAb against HEK293 (1) and BAFFR/TNFRSF13C (AA: extra 1-78)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/nbp3-27126_mouse-baffr-tnfrsf13c-mab-5a9b10-bsa-free-1042024917029.jpg%3Fv=1666702823 "Western Blot: BAFFR/TNFRSF13C Antibody (5A9B10) [NBP3-27126] - Analysis using BAFFR/TNFRSF13C mAb against HEK293 (1) and BAFFR/TNFRSF13C (AA: extra 1-78)-hIgGFc transfected HEK293 (2) cell lysate.")
![Western Blot: BAFFR/TNFRSF13C Antibody (5A9B10) [NBP3-27126] - Analysis using BAFFR/TNFRSF13C mAb against human BAFFR/TNFRSF13C (AA: extra 1-78) recombinant protein. (Expected MW is 34 kDa)](http://images.novusbio.com/fullsize/nbp3-27126_mouse-baffr-tnfrsf13c-mab-5a9b10-bsa-free-10420249181944.jpg%3Fv=1666702823)
![ELISA: BAFFR/TNFRSF13C Antibody (5A9B10) [NBP3-27126] - Black line: Control Antigen (100 ng); Purple line: Antigen (10 ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng)](http://images.novusbio.com/fullsize/nbp3-27126_mouse-baffr-tnfrsf13c-mab-5a9b10-bsa-free-1042024920234.jpg%3Fv=1666702823)
![Flow Cytometry: BAFFR/TNFRSF13C Antibody (5A9B10) [NBP3-27126] - Analysis of Raji cells using BAFFR/TNFRSF13C mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/nbp3-27126_mouse-baffr-tnfrsf13c-mab-5a9b10-bsa-free-10420249181918.jpg%3Fv=1666702823)
![Western Blot: APRIL/TNFSF13 Antibody [NBP1-76767] - Jurkat cells with TNFSF13 antibody at 1 ug/ml (A), 2 ug/ml (B), and 4 ug/ml (C).](http://images.novusbio.com/fullsize/APRIL-TNFSF13-Antibody-Western-Blot-NBP1-76767-img0004.jpg "Western Blot: APRIL/TNFSF13 Antibody [NBP1-76767] - Jurkat cells with TNFSF13 antibody at 1 ug/ml (A), 2 ug/ml (B), and 4 ug/ml (C).")
![Immunohistochemistry: APRIL/TNFSF13 Antibody - BSA Free [NBP1-76767] - Immunohistochemistry of APRIL/TNFSF13 in human prostate tissue with APRIL/TNFSF13 antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76767_rabbit-polyclonal-april-tnfsf13-antibody-271120242016937.jpg)